- Investing.com
Tasly Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally. The company provides prescription drugs covering various therapeutic areas, including cardiovascular and cerebrovascular, hepato-biliary-pancreatic, respiratory system, diabetes, tumor immunity, gastrointestinal disease, gynecological, rheumatism, soothe the nerves, pruritus, and andrological areas, as well as over-the-counter drugs. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.
Metrics to compare | 600535 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600535PeersSector | |
---|---|---|---|---|
P/E Ratio | 22.3x | 25.5x | −0.7x | |
PEG Ratio | 5.31 | 0.01 | 0.00 | |
Price/Book | 1.9x | 2.7x | 2.6x | |
Price / LTM Sales | 2.8x | 3.6x | 3.4x | |
Upside (Analyst Target) | 22.1% | 26.6% | 37.8% | |
Fair Value Upside | Unlock | 12.8% | 5.5% | Unlock |